ABH Healthcare IPO
Market Sentiment
IPO Details
Market Lot Size
IPO Reservation
Return Estimator (GMP*)
Financial Analysis
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| Revenue | 41.39 | 49.32 | 52.59 |
| Expense | 39.19 | 41.89 | 44.66 |
| Profit (PAT) | 1.66 | 5.35 | 5.64 |
| Total Assets | 51.35 | 63.90 | 85.27 |
| Company | EPS | P/E | RoNW % | NAV | Income |
|---|---|---|---|---|---|
| Sangani Hospitals Limited | 2.17 | 24.52 | 16.20 | 23.30 | 106.96 Cr |
| Maitreya Medicare Limited | -3.64 | -34.11 | -8.10 | 42.67 | 44.85 Cr |
| Asarfi Hospital Limited | 8.47 | 27.63 | 18.65 | 49.62 | 173.50 Cr |
Promoters: Kamal Baghi, Saurabh Baghi and Vaishali Saini
Strengths & Risks
- Solid profit margin — 10.7%.
- Strong return on equity — 39%.
- Elevated leverage — debt/equity of 3.20.
Compiled from this issue's live GMP, subscription, valuation and financial data, and updated as those figures change. Informational only — not investment advice. Always read the RHP before applying.
Company Information
ABH Healthcare, which operates under the brand “Anil Baghi Hospital,” is a healthcare service provider. It is a multi-speciality hospital brand that provides 25 medical specialties: cardiac sciences, neurology, minimally invasive spine and brain surgeries, medical and surgical gastroenterology, laparoscopic and bariatric surgery, urology, pulmonology, nephrology, ENT, maxillofacial surgeries, etc. ABH Healthcare offers healthcare services under various government healthcare schemes and organisations, including ECHS, Indian Railways, FCI, BSNL, and Ayushman Bharat–Sarbat Sehat Bima Yojana (ABSSBY). As of FY25, the firm includes 29 doctors and 137 nurses. Its competitive strengths are a professional management team, providing quality clinical care, modern equipment, and a track record of stable financial growth.
| Purpose | Amount (Cr) |
|---|---|
| Repayment / prepayment, in part or full, of certain of our borrowings | 17.00 |
| Funding our Working Capital Requirements; and | 4.30 |
| Funding inorganic growth through unidentified acquisitions and general corporate purposes (collectively referred to as “Objects”) | - |
Resources & Documents
ABH Healthcare Ltd., Anil Baghi Road, Ferozepur,, Punjab, Firozpur, Punjab, 152002
ABH Healthcare has set a price band of Rs 96–Rs 102 per share for an issue size of Rs 35 crore. The SME issue is scheduled to open for subscription on August 24, 2026 — 4 days from now.
ABH Healthcare, which operates under the brand “Anil Baghi Hospital,” is a healthcare service provider. It is a multi-speciality hospital brand that provides 25 medical specialties: cardiac sciences, neurology, minimally invasive spine and brain surgeries, medical and surgical gastroenterology, laparoscopic and bariatric surgery, urology, pulmonology, nephrology, ENT, maxillofacial surgeries, etc.
The issue is promoted by Kamal Baghi, Saurabh Baghi and Vaishali Saini with Fedex Securities Pvt.Ltd. acting as lead manager. Net proceeds will primarily be used towards Repayment / prepayment, in part or full, of certain of our borrowings (Rs 17 crore) and Funding our Working Capital Requirements; and (Rs 4 crore).
On fundamentals, the company is posting revenue growth of 6.6%, a profit margin of 10.7%, return on equity of 39.1% in its most recent reported period. Listed peers in this segment include Sangani Hospitals Limited (P/E 24.52x) and Maitreya Medicare Limited (P/E -34.11x) — useful reference points when evaluating the issue's pricing relative to where the broader sector are trading.
All figures below — GMP history, subscription tiers, financials and peers — are aggregated from public disclosures. Always apply through your own broker after reading the RHP.
ABH Healthcare IPO GMP — What It Means
No active grey market premium has been recorded for ABH Healthcare IPO yet. GMP is an unofficial, dealer-quoted indicator of expected listing-day demand — not a guaranteed listing price — and it can change quickly once bidding opens.
See the full ABH Healthcare GMP history and trend, or learn how grey market premium works and how reliable it is.
Related IPO
No comments yet. Be the first to share your opinion!